CSGP vs EDIT
CoStar Group Inc (CSGP) versus Editas Medicine Inc (EDIT) — a side-by-side from cached financials, not a winner call.
CoStar Group Inc (CSGP) is a real estate services company listed on US.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Latest reported CSGP revenue for 2024-12-31 was $2.74B. Net income was $138.7M. Revenue was up 11.5% from 2023-12-31 to 2024-12-31. CSGP currently screens at market cap $13.84B and trailing P/E 484.1.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
CSGP currently screens at market cap $13.84B and trailing P/E 484.1. EDIT currently screens at market cap $375.2M.
Not investment advice. Open the CSGP and EDIT stock pages for the full models.
Not investment advice.